Metraipolis › archive › dc_8a18c77d80fc

Human iPSC-derived and conventional cancer models in precision oncology: advancing patient-specific therapies from bench to bedside — Europe PMC PMID:41913269

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41913269
DOI
10.1186/s13046-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-03T16:30:57.035Z
SHA-256 of the archived text
ae43c26e82edec7e13764a311551c30e6051ef5ee495eac4a2fe316170747f2d
Stable URL of this page
https://metraipolis.com/documento/dc_8a18c77d80fc

How to cite

Human iPSC-derived and conventional cancer models in precision oncology: advancing patient-specific therapies from bench to bedside — Europe PMC PMID:41913269 — Europe PMC (en), https://europepmc.org/article/MED/41913269 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a18c77d80fc (Metraipolis archive dc_8a18c77d80fc, sha256 ae43c26e82edec7e13764a311551c30e6051ef5ee495eac4a2fe316170747f2d)
BibTeX
@misc{dc8a18c77d80fc,
  title = {Human iPSC-derived and conventional cancer models in precision oncology: advancing patient-specific therapies from bench to bedside — Europe PMC PMID:41913269},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41913269},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a18c77d80fc; sha256 ae43c26e82edec7e13764a311551c30e6051ef5ee495eac4a2fe316170747f2d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41913269. Agents can read the archived copy with the MCP tool read_document.